Number of the records: 1  

rituximab

  1. Topical termrituximab
    See linkCD20 Antibody, Rituximab (UF)
    GP2013 (UF)
    IDEC-C2B8 (UF)
    IDEC-C2B8 Antibody (UF)
    Mabthera (UF)
    Rituxan (UF)
    See alsomyší monoklonální protilátky
    antigeny CD20 (RT)
    antirevmatika (PA)
    imunologické faktory (PA)
    protinádorové látky imunologicky aktivní (PA)
    Linking entryRituximab
    ConspectD12. - 776. - 124. - 486. - 485. - 114. - 224. - 075. - 785
    D12. - 776. - 124. - 790. - 651. - 114. - 224. - 075. - 785
    D12. - 776. - 377. - 715. - 548. - 114. - 224. - 284. - 785
    NoteA murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
    DatabaseMESH
    References (2) - MESH
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all